최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기기초간호자연과학회지 = Journal of Korean biological nursing science, v.12 no.3, 2010년, pp.148 - 156
최소은 (남부대학교 간호학과) , 김희승 (가톨릭대학교 간호대학)
Purpose: Oral mucositis (OM) is a serious consequence of chemotherapy that cancer patients must undergo. The objectives of this study were to find out reliability and validity of patients self-reported daily questionnaires on OM, and the impact OM makes on daily functions. Method: To test the reliab...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
구강점막은 무엇이 높아서 화학요법으로 인해 쉽게 손상되는가? | 구강점막은 유사분열지표가 높아서 화학요법으로 인해 쉽게 손상되고 기저상피세포의 재생률 감소는 구강점막의 위축, 점막염, 궤양을 초래하게 된다(Turhal, Erdal, & Karacy, 2000). 구강점막염 발생 정도는 진단명, 화학요법의 종류, 그리고 방사선치료와의 병행 여부에 따라 차이가 있고, 구강점막염 사정도구에 따라 달라진다(Ohrn, Wahlin, & Sjoden, 2001). | |
구강점막염 발생 정도는? | 구강점막은 유사분열지표가 높아서 화학요법으로 인해 쉽게 손상되고 기저상피세포의 재생률 감소는 구강점막의 위축, 점막염, 궤양을 초래하게 된다(Turhal, Erdal, & Karacy, 2000). 구강점막염 발생 정도는 진단명, 화학요법의 종류, 그리고 방사선치료와의 병행 여부에 따라 차이가 있고, 구강점막염 사정도구에 따라 달라진다(Ohrn, Wahlin, & Sjoden, 2001). 보조화학요법을 받는 환자의 12%에서부터 조혈모세포이식을 위한 고용량 화화요법을 받는 환자의 99%까지 다양하게 보고되고 있다(Dreizen, 1990; Wardley et al. |
A handbook for reporting results of cancer treatment. (1979). Geneva, Switzerland, World Health Organization.
Beck, S. (1979). Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nursing, 2, 185-199.
Bellm, L. A., Cunningham, G., Durnell, L., Eilers, J., Epstein, J. B., Fleming, T., et al. (2002). Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: Oral mucositis patient provider advisory board. Cancer Investigation, 20, 793-800.
Brown, C. G., & Wingard, J. (2004). Clinical consequences of oral mucositis. Seminars in oncology Nursing, 20, 16-21.
Byun, Y. S., & Kim, A. K. (1996). Experimental study for construction of mouth care in chemotherapy patients. Journal of Korean Academy of Nursing, 26, 428-442.
Dreizen, S. (1990). Description and incidence of oral complications. National Cancer Institute Monography, 9, 11-15.
Duncan, G. G., Epstein, J. B., Tu, D., El Sayed, S., Bezjak, A., Ottaway, J. et al. (2005). Quality of life, mucositis and xerostomia from radiotherapy for head and neck cancers. A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck, 27, 421-428.
Eilers, J., Berger, A. M., & Petersen, M. C. (1988). Development, testing, and application of the oral assessment guide. Oncology Nursing Forum, 15, 325-330.
Eilers, J., & Epstein, J. B. (2004). Assessment and measurement of oral mucositis. Seminars in Oncology Nursing, 20, 22-29.
Elting, L. S., Keefe, D. M., Sonis, S. T., Garden, A. S., Spijkervet, F. K., Barasch, A. et al. (2008). Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer, 113, 2704-2713.
Epstein, J. B., Beaumont, J. L,. Gwede, C. K., Murphy, B., Garden, A. S., & Meredith, R. (2007). Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer, 109, 1914-1922.
Heo, S. L., Jung, M. A., Kim, H. S., Kwon, I. K., Hong, J. H., & Park, E. Y. (2003). The effect of GM-CSF oral gargle vs traditional betadine or chlorhexidine oral gargle in chemotherapy-induced stomatitis. Journal of Korean Clinical Nursing Research, 8, 169-182.
Jaroneski, L. A. (2006). The importance of assessment rating scales for chemotherapy-induced oral mucositis. Oncology Nursing Forum, 33, 1085-1090.
Jung, Y. Y. (1996). Reliability testing of an oral assessment guide for patients receiving stomatoxic treatment. The Seoul Journal of Nursing, 10, 45-51.
Kim, Y. H., Jeon, M. H., & Choi, J. S. (1997). Prevention of chemotherapy induced oral mucositis in patients with acute leukemia by the two oral care protocols: The comparision of sodium bicarbonate normal saline gargling and chlorhexidine gargling. Journal of Korean Academy of Adult Nursing, 9, 98-111.
Kushner, J. A., Lawrence, H. P., Shoval, I., Kiss, T. L., Devins, G. M., Lee, L. et al. (2008). Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale. Journal of Canadian Dental Association, 74, 59.
McGuire, D. B., Altomonte, V., Peterson, D. E., Wingard, J. R., Jones, R. J., & Grochow, L. B. (1993). Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncology Nursing Forum, 20, 1493-1502.
Nicolatou, O., Sotiropoulou-Lontou, A., Skarlatos, J., Kyprianou, K., Kolitsi, G., & Dardoufas, K. (1998). A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report. International Journal of Radiation Oncology, Biology, Physcis, 42, 551-556.
Ohrn, K. E. O., Wahlin, Y. B., & Sjoden, P. O. (2001). Oral status during radiotherapy and chemotherapy: A descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer. 9, 247- 257.
Potting, C. M. J., Blijlevens, N. A. M., Donnelly, J. P., Feuth, T., & Van Achterberg, T. (2006). A scoring system for the assessment of oral mucositis in daily nursing practice. European Journal of Cancer Care, 15, 228-234.
Quinn, B., Potting, C. M., Stone, R., Blijlevens, N. M., Fliedner, M., Margulies, A., et al. (2008). Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. European Journal of Cancer, 44, 61-72.
Rogers, B. B. (2001). Mucositis in the oncology patient. Nursing Clinics of North America, 36, 745-760.
Scully, C., Sonis, S., & Diz, P. D. (2006). Oral mucositis. Oral Diseases, 12, 229-241.
Sonis, S. T., Eilers, J. P., Epstein, J. B., LeVeque, F. G., Liggett, W. H., Jr, Mulagha, M. T. et al. (1999). Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer, 85, 2103-2113.
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., et al. (2004). Perspectives on cancer therapyinduced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer, 100 (9Suppl), 1995S-2025S.
Stiff, P. J., Emmanouilides, C., Bensinger, W. I., Gentile, T., Blazar, B., Shea, T. C., et al. (2006). Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. Journal of Clinial Oncology, 24, 5186-5193.
Stiff, P. J., Erder, H., Bensinger, W. I., Emmanouilides, C., Gentile, T., Isitt, J. et al. (2006). Reliability and validity of a patient selfadministered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplantation, 37, 393-401.
Tomlinson, D., Judd, P., Hendershot, E., Maloney, A. M., & Sung, L. (2007). Measurement of oral mucositis in children: A review of the literature. Supportive Care in Cancer, 15, 1251-1258.
Turhal, N. S., Erdal, S., & Karacay, S. (2000). Efficacy of treatment to relieve mucositis -induced discomfort. Supportive Care in Cancer, 8, 55-58.
Wardley, A. M., Jayson, G. C., Swindell, R., Morgenstern, G. R., Chang, J., Bloor, R., et al. (2000). Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology, 110, 292-299.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.